Institutional investors hold a majority ownership of GERN through the 56.06% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $26.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TFS CAPITAL LLC Bought 128.1 Thousand shares of Geron Corp
QUOTIENT INVESTORS LLC Bought 17.3 Thousand shares of Geron Corp
TRADEWORX, INC. Bought 14.9 Thousand shares of Geron Corp